| 000 | 02644nam a2200337 a 4500 | ||
|---|---|---|---|
| 001 | vtls000041206 | ||
| 003 | KUKTEM | ||
| 005 | 20251117145504.0 | ||
| 008 | 090810t2010 flua f b 001 0 eng d | ||
| 020 | _a9781420084221 (hardcover : alk. paper) | ||
| 020 | _a1420084224 (hardcover : alk. paper) | ||
| 039 | 9 |
_a201107132203 _bVLOAD _c201010051526 _dfauzi _c200908141654 _dVLOAD _c200908141638 _dVLOAD _y200908102025 _zjamee |
|
| 040 | _aUMP | ||
| 090 | _aRS100 .P43 2010 | ||
| 245 | 0 | 0 |
_aPharmacoeconomics : _bfrom theory to practice / _cedited by Renée J. G. Arnold |
| 260 |
_aBoca Raton, FL : _bCRC Press, _cc2010 |
||
| 300 |
_axiv, 243 p. : _bill. ; _c25 cm. |
||
| 490 | 1 |
_aDrug discovery series ; _v13 |
|
| 504 | _aIncludes bibliographical references and index | ||
| 505 | 0 | _aIntroduction to pharmacoeconomics / William F. McGhan -- Decision modeling techniques / Mark S. Roberts and Ken Smith -- Cost of illness / Renée J.G. Arnold -- Markov modeling in decision analysis / J. Robert Beck -- Retrospective database analysis / Renée J.G. Arnold and Sanjeev Balu -- What is cost-minimization analysis? / Alan Haycox -- Cost-effectiveness analysis / Kenneth J. Smith and Mark S. Roberts -- Budget impact analysis / Lieven Annemans -- Cost-utility analysis : a case study of a quadrivalent human Papillomavirus vaccine / Erik J. Dasbach, Ralph P. Insinga, and Elamin H. Elbasha -- Some problems/assumptions in pharmacoeconomic analysis / Stuart Birks -- Patient-reported outcome measures / Dianne Bryant, Gordon Guyatt, and Renée J.G. Arnold -- Sensitivity analysis / Maarten J. Postma -- Use of pharmacoeconomics in drug reimbursement in Australia, Canada, and the United Kingdom : what can we learn from international experience? / Michael Drummond and Corinna Sorenson -- Pharmacoeconomics in disease management : practical applications and persistent challenges / Ryung Suh and David Atkins -- Computer aided decision making from drug discovery to pharmacoeconomics / Sean Ekins and Renée J.G. Arnold -- Speculations on the future challenges and value of pharmacoeconomics / J. Jaime Caro, Denis Getsios, and Rachael L. Fleurence | |
| 650 | 0 |
_aDrugs _xCost effectiveness |
|
| 650 | 0 |
_aPharmacy _xEconomic aspects |
|
| 650 | 0 | _aDecision making | |
| 650 | 1 | 2 | _aEconomics, Pharmaceutical |
| 650 | 2 | 2 | _aCosts and Cost Analysis |
| 650 | 2 | 2 | _aDecision Making |
| 650 | 2 | 2 |
_aOutcome Assessment (Health Care) _xeconomics |
| 700 | 1 | _aArnold, Renee J. G. | |
| 830 | 0 |
_aDrug discovery series ; _v13 |
|
| 999 |
_aVIRTUA40 _c47279 _d47285 |
||
| 999 | _aVTLSSORT0080*0200*0201*0400*0900*2450*2600*3000*4900*5040*5050*6500*6501*6502*6503*6504*6505*6506*7000*8300*9991 | ||